Skip to content
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

President Joe Biden speaks during an event in the East Room of the White House in Washington, Thursday, March 23, 2023, celebrating the 13th anniversary of the Affordable Care Act. (AP Photo/Susan Walsh)

Biden uses Obamacare anniversary to ding GOP budget plans

President Biden marked Obamacare's 13th anniversary on Thursday by highlighting coverage gains and re-engaging with GOP lawmakers who've taken cuts to Social Security and Medicare off the table but are eyeing ways to scale back the 2010 health law or place new limits on Medicaid coverage for the poor. Published March 23, 2023

Moderna CEO and Director Stephane Bancel arrives to testify to the Senate HELP Committee on the price of COVID-19 vaccine, Wednesday, March 22, 2023, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)

Moderna CEO defends COVID vaccine price hike, citing pivot to endemic phase

Moderna is hiking the price of its COVID-19 shot because it faces "increased complexity and risk" as the pandemic stabilizes and the life-saving vaccine pivots from a government-funded product to a commercial one, CEO Stephane Bancel told Congress Wednesday in a Senate hearing on what taxpayers are owed after they support critical medicine. Published March 22, 2023

Hywind Scotland, the world's first commercial wind farm using floating wind turbines, is visible off the coast of Scotland in August 2017. Tuesday, Dec. 6, 2022, marks the first-ever U.S. auction for leases to develop commercial-scale floating wind farms in the deep waters off the West Coast.  (Woldcam/Equinor via AP)

House Republicans want to pause offshore wind projects

House GOP lawmakers from the Northeast are calling for a federal moratorium on offshore wind projects until the full environmental and economic impacts of the ventures are understood. Published March 22, 2023

This undated photo made available by the Centers for Disease Control and Prevention shows a strain of Candida auris cultured in a petri dish at a CDC laboratory. In a CDC paper published by the Annals of Internal Medicine on Monday, March 20, 2023, U.S. cases of the dangerous fungus tripled over just three years, and more than half of states have now reported it. (Shawn Lockhart/Centers for Disease Control and Prevention via AP, File)

CDC warns of potentially deadly drug-resistant fungus

The Centers for Disease Control and Prevention is sounding the alarm over rising cases of Candida auris, a fungus that is resistant to a number of medications and can kill people who are already sick. Published March 21, 2023

Jason Sudeikis, who plays the title character in the Apple TV+ series “Ted Lasso”, center, speaks during the daily press briefing with White House press secretary Karine Jean-Pierre, left, and fellow cast member Hannah Waddingham, right, at the White House in Washington, Monday, March 20, 2023. (AP Photo/Susan Walsh)

‘Ted Lasso’ cast visits White House to bolster mental health agenda

Actor Jason Sudeikis and the cast of "Ted Lasso" visited the White House on Monday to highlight the importance of checking in with relatives, neighbors and friends as President Biden tries to put mental health on par with physical health and fund new services. Published March 20, 2023

A Jackson-Hinds Comprehensive Health Center nurse loads a syringe with a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. Moderna recently announced early evidence that its updated booster induced BQ.1.1-neutralizing antibodies. (AP Photo/Rogelio V. Solis)

Vaccine makers pick Senate fight over soaring prices; fall boosters cost up to $130

Prominent drugmakers want to more than quadruple the prices of their COVID-19 vaccines when the shots transition to the commercial market later this year, sparking a showdown with congressional lawmakers who say Pfizer and Moderna benefited from taxpayer largesse and are now gouging the public to pad handsome profits. Published March 18, 2023